Coya Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-10.3	-7.99	-12.24	-4.89
Depreciation & Amortization	0.03	0.03	0.03	0.02
Share-Based Compensation	1.13	0.87	0.21	0.23
Other Operating Activities	3.97	-4.1	4.77	0.74
Operating Cash Flow	-5.18	-11.19	-7.24	-3.9
Capital Expenditures	0	0	0	-0.14
Acquisitions	-0.22	-0.54	-0.53	0
Investing Cash Flow	-0.22	-0.54	-0.53	-0.14
Share Issuance / Repurchase	25.55	38.43	0	0
Debt Issued / Paid	0	0	9.47	0
Other Financing Activities	-0.13	-	-0.11	-0.34
Financing Cash Flow	25.42	38.43	9.36	-0.34
Net Cash Flow	19.67	26.69	1.59	-4.38
Free Cash Flow	-5.18	-11.19	-7.24	-4.04
Free Cash Flow Margin	-84.50%	-186.41%	-	-
Free Cash Flow Per Share	-0.36	-1.10	-2.79	-1.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).